Vecuronium bromide is available as a lyophilized cake or powder in vials containing 10 or 20 mg of the drug.3661 The vials also contain citric acid anhydrous, mannitol, and dibasic sodium phosphate anhydrous.3661 Sodium hydroxide and/or phosphoric acid also may be present to adjust the pH.3661
Ten- and 20-mg vials can be reconstituted with 10 and 20 mL, respectively, of a compatible diluent to yield a 1-mg/mL solution.3661 When the lyophilized cake or powder is reconstituted with a compatible solution that does not contain an antimicrobial preservative (e.g., sterile water for injection), the vial is a single-use container; such vials should be stored under refrigeration, used within 24 hours, and the unused portion should be discarded.3661 When the lyophilized cake or powder is reconstituted with bacteriostatic water for injection, which contains benzyl alcohol 0.9%, the vial is a multi-dose container; the reconstituted solution may be used for up to 5 days when stored at room temperature or under refrigeration.3661 Reconstituted solutions prepared with bacteriostatic water for injection are not for use in newborns.3661
pH
From 3.5 to 4.5.3661
Osmolality
The osmolality of vecuronium bromide 4 mg/mL was determined to be 292 mOsm/kg.1233
Vecuronium bromide is for intravenous use only.3661 The drug may be administered by intravenous bolus injection or by intravenous infusion following dilution in a compatible diluent to a concentration of 0.1 or 0.2 mg/mL.3661
Intact vials of vecuronium bromide should be stored at room temperature and retained in the original carton to protect from light.3661 When the lyophilized cake or powder is reconstituted with sterile water for injection, the vial is a single-dose container; such vials should be stored under refrigeration, used within 24 hours, and the unused portion should be discarded.3661 When the lyophilized cake or powder is reconstituted with bacteriostatic water for injection, the vial is a multiple-dose container; the solution may be used for up to 5 days when stored at room temperature or under refrigeration.3661
pH Effects
Reconstituted solutions of vecuronium bromide have an acid pH and should not be combined with or administered simultaneously through the same needle or intravenous line as alkaline solutions (e.g., barbiturate solutions).3661
Syringes
Vecuronium bromide 1 mg/mL in sterile water for injection and packaged in plastic syringes was found to be stable with no loss of drug for 21 days at room temperature and refrigerated.2735
Standardize 4 Safety
One or more standardized concentrations for this drug have been established through Standardize 4 Safety (S4S), a national patient safety initiative to reduce medication errors, especially during transitions of care. (See Standardize 4 Safety in Users Guide.) Recommendations developed to date through this initiative are available at www.ashp.org/pharmacy-practice/standardize-4-safety-initiative.
Table 1: Standardize 4 Safety Continuous IV Infusion Standard Concentrations for Vecuronium3635; 3636
Patient Population | Concentration Standards | Dosing Units |
---|---|---|
Adultsa | 1 mg/mL | mcg/kg/minute (note dosing units differ from concentration units) |
Pediatric patients (50 kg) | 1 mg/mLb | mg/kg/hour |
a Paralytics are recommended to be administered as straight drug. This provides consistency between operating room and the ICU, and eliminates potential compounding errors.b Babies weighing under 500 grams may require a lower concentration.
For a list of references cited in the text of this monograph, search the monograph titled References.